Cibc Private Wealth Group, LLC Aldeyra Therapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $56.1 Billion
- Q3 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 10,505 shares of ALDX stock, worth $53,260. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,505
Previous 40,953
74.35%
Holding current value
$53,260
Previous $235,000
77.02%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ALDX
# of Institutions
143Shares Held
39.9MCall Options Held
344KPut Options Held
71.7K-
Knoll Capital Management, LLC Miami, FL5.48MShares$27.8 Million15.99% of portfolio
-
Perceptive Advisors LLC New York, NY5.22MShares$26.5 Million0.06% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$18.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$18.2 Million0.0% of portfolio
-
Ardsley Advisory Partners LP Stamford, CT1.9MShares$9.63 Million1.4% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $296M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...